ITB-MED

Itb-med email format

Verified email-pattern data for Itb-Med is currently limited. You can still use the company insights and contact sections below.
ITB-MED is developing the proprietary antagonistic CD2-directed monoclonal antibody, TCD601 (siplizumab), for several indications. ITB-MED is wholly committed to advancing and exploring the potential of TCD601, with a particular focus on its applications in transplantation and autoimmunity. The efforts extend to comprehensive worldwide clinical trials. ITB-MED is actively investigating further preclinical therapies to expand the reach of its novel immune-modulating approaches.

Company Details

Employees
47
Founded
-
Address
110 E 59th St, 28,sweden
Industry
Biotechnology Research
HQ
New York
Looking for a particular ITB-MED employee's phone or email?

Itb-Med Questions

Explore related pages

Related company profiles:

Top ITB-MED Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant